Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
about
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetesImpaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte functionNovel therapeutics for type 2 diabetes: insulin resistance.The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.Vascular Smooth Muscle as a Target for Novel Therapeutics.Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.
P2860
Q30249371-BD144EE3-B894-4086-9863-11EFD7945111Q34956310-EF5F9891-7D4D-442D-A778-0D747690093BQ37436828-351714DD-7539-4E81-A6C7-43C860F5DC47Q37439991-8B4D5E78-F8AD-4348-B90D-8947F4766ACDQ38259507-1FEF825D-9CBE-4C04-9F40-C8BF83438D17Q38537774-BAA69C40-39F5-4300-A2E7-7D91898FAC1BQ38567506-FF9446EB-F50F-4837-B356-C41A4C3EB51EQ46429786-6BBE446C-91ED-43AE-B109-3FEAF3A41096
P2860
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
description
2014 nî lūn-bûn
@nan
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@en
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@nl
type
label
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@en
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@nl
prefLabel
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@en
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@nl
P2860
P356
P1433
P1476
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
@en
P2093
Bennett C Meier
Bridget K Wagner
P2860
P304
P356
10.2217/EPI.14.11
P577
2014-04-01T00:00:00Z